Science & Research
New Research Reveals How Fiber and Antioxidants Can Counteract Junk Food Health Risks
Scientific studies spanning decades demonstrate that diets rich in fiber and antioxidants can mitigate the harmful effects of junk food, offering a less restrictive approach to cholesterol and weight management while reducing chronic disease risks.
Quirkitude Releases Book on Ancient Herbal Remedies for Neurodivergent Wellness
Quirkitude's new book combines ancestral herbal wisdom with modern science to provide natural alternatives for stress, anxiety, and neurodivergent balance, addressing growing demand for holistic mental health approaches.
Northwest Battle Buddies to Celebrate 300th Service Dog Team as Study Confirms PTSD Treatment Benefits
Northwest Battle Buddies' milestone of pairing 300 service dogs with combat veterans comes as a landmark study validates the significant therapeutic impact these dogs provide in reducing PTSD symptoms and improving veterans' quality of life.
NRx Pharmaceuticals to Present Depression Treatment Advancements at Noble Capital Markets Conference
NRx Pharmaceuticals will present its innovative depression treatments including a low-dose D-Cycloserine product that enhances Transcranial Magnetic Stimulation effectiveness and discuss expanded clinical operations and VA collaborations for treating suicidal depression and PTSD.
Safe Pro Group AI Identifies Over 36,000 Landmines in Ukrainian Battlefields
Safe Pro Group's AI technology has detected more than 36,000 landmines across 22,500 acres in Ukraine, demonstrating significant advancement in battlefield safety and explosive detection capabilities.
Boston University Professor Honored with Prestigious Mentorship Award for Cardiovascular Research Training
Dr. Emelia J. Benjamin of Boston University receives the 2025 Eugene Braunwald Academic Mentorship Award for her extensive work mentoring the next generation of cardiovascular researchers and clinicians, highlighting the critical role of mentorship in advancing cardiovascular science.
Cardiovascular Complications Affect 1 in 7 Pregnancies as Risk Factors Rise Sharply
New research reveals cardiovascular complications impact 15% of pregnancies, driven by increasing rates of obesity, hypertension, diabetes and high cholesterol over the past two decades.
China's High-Oil Peanut Varieties Show Promise but Face Breeding Challenges
A comprehensive study of 238 high-oil peanut varieties in China reveals promising oil content up to 61% but identifies critical trade-offs between oil and protein content and limited disease resistance, providing crucial insights for future breeding strategies to enhance global peanut production.
Datavault AI Partners With Korea Aerospace University to Launch Nation's First Digital Credentialing System
Datavault AI's collaboration with Korea Aerospace University establishes South Korea's inaugural digital credentialing platform for pilots while advancing quantum computing and digital twin research in aerospace innovation.
DGE to Host 5th Investigator-Initiated Trials Summit in Philadelphia, Addressing Clinical Research Challenges
The upcoming 5th Investigator-Initiated Trials Summit in Philadelphia brings together life sciences professionals to address critical challenges in clinical research programs, highlighting the importance of collaborative solutions in advancing medical innovation.
Quantum BioPharma Advances Multiple Sclerosis Treatment Toward Clinical Trials
Quantum BioPharma has received final toxicity reports for its Lucid-MS drug candidate, clearing a critical regulatory hurdle toward Phase 2 clinical trials for treating multiple sclerosis by targeting demyelination.
Quantum Critical Metals Confirms Promising Magnetic Anomaly at Quebec NMX East Project
Quantum Critical Metals Corp. has completed airborne surveys revealing a magnetic anomaly at its NMX East Property in Quebec that shows striking similarities to the neighboring Nisk nickel-PGE deposit, signaling potential for significant mineral discovery.
OHSU Receives $6.7M NIH Grant to Study Cannabis Effects in HIV-Positive Pregnant Women
Oregon Health and Science University researchers secured substantial federal funding to investigate marijuana's impact on HIV-positive pregnant women, addressing critical gaps in medical cannabis research and maternal health.
Sapu Nano Receives Australian Ethics Approval for Breast Cancer Drug Trial
Sapu Nano's Sapu003, an injectable form of Everolimus using proprietary nanoparticle technology, has received HREC approval for human clinical trials in Australia, potentially offering more effective breast cancer treatment through improved drug delivery.
Quantum BioPharma Appoints Leading MS Expert Dr. Jack Antel as Clinical Advisor for Lucid-MS Development
Quantum BioPharma has strengthened its multiple sclerosis program by appointing renowned neurologist Dr. Jack Antel to guide the clinical development of Lucid-21-302 as the investigational drug advances toward Phase 2 trials.
NYU's Judith Hochman to Receive 2025 Research Achievement Award for Transformative Cardiology Research
Dr. Judith Hochman's recognition by the American Heart Association highlights her pivotal clinical trials that have reshaped global cardiology guidelines and improved patient outcomes in ischemic heart disease.
National Survey Reveals Nearly Half of Americans Suffer From Unexplained Pain and Illness
A new national survey shows that 48% of Americans experience unexplained chronic pain or illness, highlighting the urgent need for greater awareness and access to neuroplastic treatments that could transform healthcare outcomes.
FDA Guidance Accelerates Lantern Pharma's Pediatric Brain Cancer Therapy Development
Lantern Pharma received FDA guidance that will help advance its LP-184/STAR-001 therapy for rare pediatric brain cancers toward clinical trials planned for 2026, representing significant progress in treating conditions with limited options.
Soligenix Expands European Medical Advisory Board to Advance Cutaneous T-Cell Lymphoma Treatment
Soligenix Inc. has expanded its European Medical Advisory Board to guide the confirmatory Phase 3 trial of HyBryte for early-stage cutaneous T-cell lymphoma, strengthening European engagement ahead of potential commercialization of this novel photodynamic therapy.
Tonix Pharmaceuticals Advances TNX-2900 for Prader-Willi Syndrome Into Phase 2 Clinical Trial
Tonix Pharmaceuticals has received FDA clearance to begin Phase 2 trials for TNX-2900, a potential treatment for Prader-Willi syndrome, marking significant progress for a rare genetic disorder that causes life-threatening childhood obesity.
Scorpion Venom Compound Shows Promise in Brain Cancer Treatment Research
Researchers are exploring how scorpion venom compounds could revolutionize brain tumor treatment by helping the immune system target glioblastoma more effectively.
Curdlan Innovation Cuts Pineapple Jam Production Time by Two-Thirds While Maintaining Quality
Researchers have discovered that curdlan, a natural polysaccharide, can reduce pineapple jam cooking time from three hours to just one while improving texture and stability without compromising taste, offering a cost-effective alternative to expensive pectin that could transform fruit preservation and reduce food waste.
EHCOnomics Discovers Primordia, a Machine-Originated Logic System That Defines When AI Must Stop
Canadian research organization EHCOnomics has discovered Primordia, a machine-generated structural logic that enables AI systems to halt when they can no longer act with certainty, potentially representing a breakthrough in AI safety and governance comparable to TCP/IP's impact on internet communication.
Lexaria Bioscience Secures $4 Million in Capital to Advance 2026 Research and Development Initiatives
Lexaria Bioscience Corp. has completed a $4 million registered direct offering, providing crucial funding to advance its 2026 R&D and business development plans for its DehydraTECH drug delivery technology.
Soligenix Advances Psoriasis Treatment Trial with Promising Early Results
Soligenix is progressing its SGX302 psoriasis treatment through clinical trials, offering potential for a new therapeutic option for millions affected by the autoimmune skin condition.
Fathom Nickel Expands Exploration at Gochager Lake Following Wildfire Exposure
Fathom Nickel Inc. has discovered significant mineralized extensions at its Gochager Lake Project in Saskatchewan after wildfires exposed new rock outcrops, potentially expanding the project's economic potential.
Tevard Biosciences Demonstrates Breakthrough Protein Restoration in Genetic Muscle and Heart Diseases
Tevard Biosciences presented preclinical data showing its tRNA-based therapy can restore 70% of functional proteins in Duchenne muscular dystrophy and dilated cardiomyopathy models, potentially enabling clinical advancement for genetic diseases affecting millions worldwide.
UCSF Researcher Receives Prestigious Award for Study on Postpartum Cardiovascular Care Disparities
Dr. Megan McLaughlin's award-winning research reveals significant gaps in postpartum cardiovascular care for women with pregnancy-related hypertension, highlighting critical opportunities to improve long-term heart health in high-risk populations.
Fairchild Gold Reports Exceptional 34% Copper Grades at Nevada Titan Project, Revealing Major Porphyry Potential
Fairchild Gold's discovery of high-grade copper mineralization up to 34% Cu at its Nevada Titan Project signals a significant porphyry system that had been overlooked for decades in the historic Goodsprings Mining District.
New Research Reveals Menopause's Significant Impact on Multiple Sclerosis Symptoms and Comorbidities
Groundbreaking research presented at the ECTRIMS 2025 conference demonstrates how hormonal changes during menopause influence both initial symptoms and comorbidities in women with multiple sclerosis, potentially guiding future treatment development.